Peter Camaj
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 08, 2025
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 08, 2019
Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: December 16, 2016
miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
Journal: Annals of surgery
Published: August 09, 2016
Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.
Journal: International journal of oncology
Published: January 14, 2016
KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
Journal: Future oncology (London, England)
Published: July 11, 2015
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
Journal: Anti-cancer drugs
Published: December 17, 2014
Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.
Journal: Targeted oncology
Published: October 17, 2014
Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotype.
Journal: Oncotarget
Published: August 12, 2014
Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Journal: Molecular cancer research : MCR
Published: December 05, 2013
Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
Journal: Targeted oncology
Published: November 19, 2013
Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
Journal: Stem cells and development
Published: September 12, 2013
Last Updated: 09/26/2026